These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3332096)

  • 21. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification.
    Foa R; Migone N; Fierro MT; Basso G; Lusso P; Putti MC; Giubellino MC; Saitta M; Miniero R; Casorati G
    Exp Hematol; 1987 Oct; 15(9):942-5. PubMed ID: 3115807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies.
    Link M; Warnke R; Finlay J; Amylon M; Miller R; Dilley J; Levy R
    Blood; 1983 Oct; 62(4):722-8. PubMed ID: 6603882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies.
    Coccia PF
    Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518
    [No Abstract]   [Full Text] [Related]  

  • 28. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
    Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
    Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemias and lymphomas of thymic differentiation.
    Borowitz MJ; Falletta JM
    Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface markers define human lymphoid malignancies with differing prognoses.
    Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
    Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
    Said JW; Pinkus GS
    Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anomalous HLA reactivity in the typing of neoplastic lymphoreticular cells.
    Huntington SJ; Davey FR
    Prog Clin Biol Res; 1977; 16():91-102. PubMed ID: 71745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse.
    Lauer S; Piaskowski V; Camitta B; Casper J
    Leuk Res; 1982; 6(6):769-74. PubMed ID: 6961270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.